EUVIMEDEUVIMED entdecken
Übersichtsarbeit

New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs

Wei Peng, Xiaoyan Pan iD, Shiqun Wang, Guang Huang iD, Yufeng Qian

Journal of Medicinal Chemistry · 23.04.2026 · 69 (8) · 8688-8718

DOI: 10.1021/acs.jmedchem.5c03330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.04.2026. Verfasst von Wei Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Proteolysis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative paradigm in pharmaceutical research. Despite significant progress in PROTACs, they are overwhelmingly dominated by the recruitment of a very restricted subset of canonical E3 ligases (e.g., CRBN and VHL), which hinders their potential therapeutic applications. As a result, recent developments have led to the emergence of PROTACs that utilize nonclassical E3 ligases. Another challenge is systemic toxicity caused by degradation on-target degradation in nonintended tissues, prompting the development of pre-PROTACs to achieve conditional and spatiotemporal modulation of target protein levels. Herein, we provide a comprehensive summary and discussion of recent advancements in PROTACs based on "novel" E3 ligases, as well as PROTAC prodrugs activated by external stimuli and the tumor microenvironment, highlighting prospects for the design of effective and selective PROTACs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesProteolysisHumansProteolysis Targeting ChimeraAnimalsProdrugsDrug Design

Substanzen

Ubiquitin-Protein LigasesProteolysis Targeting ChimeraProdrugs

Autor:innen und Institutionen

  • Medical Research Center, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, China.
  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
  • Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310…
  • Center for Medical Research and Innovation in Digestive System Tumors, Ministry of Education, Hangzhou, Zhejiang 310009, China.
  • Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Neurosurgery, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, China.

ORCID-Profile: Xiaoyan Pan, Guang Huang

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Shaoxing People's Hospital
  • Shaoxing Health Science and Technology Project of China
  • Zhejiang Province Traditional Chinese Medicine Science and Technology Project of China

Zitieren

APA

Peng, W., Pan, X., Wang, S., Huang, G., & Qian, Y. (2026). New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs. Journal of Medicinal Chemistry, 69(8), 8688-8718. https://doi.org/10.1021/acs.jmedchem.5c03330

Vancouver

Peng W, Pan X, Wang S, Huang G, Qian Y. New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs. Journal of Medicinal Chemistry. 2026;69(8):8688-8718. doi:10.1021/acs.jmedchem.5c03330

BibTeX
@article{Peng2026,
  author = {Peng, Wei and Pan, Xiaoyan and Wang, Shiqun and Huang, Guang and Qian, Yufeng},
  title = {New PROTAC Designs for Targeted Protein Degradation in 2021–2025: Novel E3 Ligases and Pre-PROTACs},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {8},
  pages = {8688--8718},
  doi = {10.1021/acs.jmedchem.5c03330}
}
Kostenlos starten →